8 results
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
28 Aug 23
Current report (foreign)
4:49pm
in respect of which they are appointed proxy FOR the Adjournment Proposal.
STATEMENT OF EXECUTIVE COMPENSATION
Compensation Discussion and Analysis … for individuals with similar capabilities and experience. In regard to the Corporation’s current executive compensation arrangements, the Board has also
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
22 Aug 22
Current report (foreign)
11:39am
the directors to fix the remuneration of the auditor.
STATEMENT OF EXECUTIVE COMPENSATION
Compensation Discussion and Analysis
Objectives
The Corporation … has historically relied on the experience of its Board and independent compensation consultants in setting executive compensation. In considering
20-F
2022 FY
MDNAF
Medicenna Therapeutics Corp.
22 Jun 22
Annual report (foreign)
5:04pm
.
6.B. Compensation
STATEMENT OF EXECUTIVE COMPENSATION
Compensation Discussion and Analysis
Objectives
The Company has historically relied … on the experience of its Board and independent compensation consultants in setting executive compensation. In considering compensation awards, the Board
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
1 Sep 21
Current report (foreign)
8:00am
the next annual meeting of Shareholders, and authorizing the directors to fix the remuneration of the auditor.
STATEMENT OF EXECUTIVE COMPENSATION
Compensation … consultants in setting executive compensation. In considering compensation awards, the Board has considered the skill level of its executives as well
6-K
EX-99.1
wsl1hn
4 Sep 20
Current report (foreign)
2:50pm
S-8
EX-99.4
yc907y
31 Jul 20
Registration of securities for employees
8:43am
F-10
EX-4.4
rde9ui3c6pr7mlz
3 Jun 20
Registration of securities (Canada)
3:54pm
- Prev
- 1
- Next